High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.
Vigorous and rapid air exchanges might not always be a good thing when it comes to levels of coronavirus particles in a multiroom building, according to a new modeling study.
PNNL teamed with academia and industry to develop a novel zero-emission methane pyrolysis process that produces both hydrogen and high-value carbon solids suitable for an array of manufacturing applications.
PNNL’s newest solvent captures carbon dioxide from power plants for as little as $47.10 per metric ton, marking a significant milestone in the journey to lower the cost of carbon capture.
Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
In a new review, PNNL researchers outline how to convert stranded biomass to sustainable fuel using electrochemical reduction reactions in mini-refineries powered by renewable energy.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.